Therapy News and Research

RSS

Designing a new treatment to treat migraine effectively

In this interview, we speak to Mudra Kapoor, Vice President of Global Medical Affairs for Neuroscience at AbbVie, about atogepant, their new treatment option for migraine.

From AbbVie 26 Sep 2022

Deep brain stimulation as obsessive-compulsive disorder treatment

In a recent study published in the Journal of Neurology, Neurosurgery & Psychiatry, researchers investigated the effectiveness of deep brain stimulation (DBS) against treatment-resistant obsessive-compulsive disorder (OCD).

25 Sep 2022

Cancer survival rate rises in the US

In a recent article by the American Association for Cancer Research (AACR), the researchers highlighted basic, translational, and clinical cancer research and cancer-related population sciences in the 12th edition of its annual Cancer Progress Report.

25 Sep 2022

How smallpox and monkeypox viruses affect the nervous system

A recent study provides an overview of existing literature on the complications of infection with both smallpox and monkeypox virus.

25 Sep 2022

Genome editing approaches enable precise gene correction and disease rescue in inherited retinal diseases

In a new paper, University of California, Irvine researchers explain how precision genome editing agents have enabled precise gene correction and disease rescue in inherited retinal diseases (IRDs).

23 Sep 2022

Investigating a potential new treatment for glioblastomas

A research question posed in Pankaj Desai's lab has led to a decade of research, a clinical trial and major national funding to further investigate a potential new treatment for the most deadly form of brain tumors.

23 Sep 2022

Study identifies a potential non-invasive therapy that could check the progress of Alzheimer's disease

A new study conducted by the scientist of the UMA Inés Moreno, in collaboration with the University of Texas, has identified a potential non-invasive therapy that could check the progress of Alzheimer's disease, "the major form of dementia in the elderly population".

23 Sep 2022

Scientists create new tool to identify genomic safe harbor sites in specific tissues

Scientists at St. Jude Children's Research Hospital have created a tool that can find safe places to introduce genes into human DNA.

22 Sep 2022

Cleveland Clinic’s ROBIN center may pave way for more effective radiation, immunotherapy treatments

Cleveland Clinic received a $7.9 million five-year grant from the National Cancer Institute at the National Institutes of Health to form one of three national centers as part of the newly established Radiation Oncology-Biology Integration Network (ROBIN).

22 Sep 2022

Newly discovered gene marker may lead to a precision treatment for pancreatic cancer

Researchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancreatic ductal adenocarcinoma (PDAC).

22 Sep 2022

Monon Bioventures receives SBIR grant to develop glioblastoma therapeutic created at Purdue

Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.

22 Sep 2022

New imaging approach could help accelerate the development of new treatments for eye diseases

Researchers have developed a simple and fast way to perform optoretinography, an imaging technique that measures light-induced functional activity in the eye's retina, the network of neurons in the back of our eyes responsible for detecting light and initiating vision.

22 Sep 2022

Patients with late-stage knee OA incur high costs for nonoperative treatments before total knee arthroplasty

In the year before total knee arthroplasty (TKA), patients incur considerable costs for nonoperative treatments and other procedures for osteoarthritis (OA) – raising questions about the value of those procedures, reports a study in The Journal of Bone & Joint Surgery.

22 Sep 2022

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

In a new study, a team of researchers explored the effect of immune checkpoint blockade (ICB)-induced expansion of age-associated B cells (ABCs) on COVID-19 vaccine-derived humoral immunity in patients with cancer and inborn errors of immunity (IEI).

22 Sep 2022

New board members bring significant leadership experience in the biotech sector

Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat disease, is pleased to announce the appointment of three new members to its Board of Directors: Dr. Nancy Krieger, Dr. Don Haut, and Dr. Devyn Smith.

From Aspect Biosystems 22 Sep 2022

An unusual case of Monkeypox virus transmission by needlestick injury

In a recent study published in the U.S. Centers for Disease Control and Prevention journal Emerging Infectious Diseases, researchers described an unusual case of patient-to-healthcare worker (HCW) monkeypox virus (MPXV) transmission via a needlestick injury that occured in Brazil.

21 Sep 2022

New genetically-targeted MND therapy could be a turning point for patient care

Scientists believe a new genetically-targeted therapy to treat motor neurone disease (MND) could be a turning point for patient care, after the results of a Phase 3 clinical trial showed significant physical benefits for patients after 12 months.

21 Sep 2022

Artificial intelligence could help fast-track dementia diagnosis

Different forms of dementia could be spotted sooner and more easily by analyzing recordings of patients' electrical brain activity using artificial intelligence (AI), according to new research.

21 Sep 2022

What is the efficacy of aerosol treatment for SARS-CoV-2 infection?

In a new study, researchers assessed the efficacy of the scFv76 antibody against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lung damage.

21 Sep 2022

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Health~Holland has awarded close to € 800,000 to a public-private partnership between UMC Utrecht, Artizan Biosciences, Inc. (USA) and MicroViable Therapeutics (Spain) to unravel how the intestinal microbiota can be exploited to boost cancer immunotherapy and limit therapy side-effects.

21 Sep 2022

Therapy News and Research

Designing a new treatment to treat migraine effectively

Deep brain stimulation as obsessive-compulsive disorder treatment

Cancer survival rate rises in the US

How smallpox and monkeypox viruses affect the nervous system

Genome editing approaches enable precise gene correction and disease rescue in inherited retinal diseases

Investigating a potential new treatment for glioblastomas

Study identifies a potential non-invasive therapy that could check the progress of Alzheimer's disease

Scientists create new tool to identify genomic safe harbor sites in specific tissues

Cleveland Clinic’s ROBIN center may pave way for more effective radiation, immunotherapy treatments

Newly discovered gene marker may lead to a precision treatment for pancreatic cancer

Monon Bioventures receives SBIR grant to develop glioblastoma therapeutic created at Purdue

New imaging approach could help accelerate the development of new treatments for eye diseases

Patients with late-stage knee OA incur high costs for nonoperative treatments before total knee arthroplasty

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

New board members bring significant leadership experience in the biotech sector

An unusual case of Monkeypox virus transmission by needlestick injury

New genetically-targeted MND therapy could be a turning point for patient care

Artificial intelligence could help fast-track dementia diagnosis

What is the efficacy of aerosol treatment for SARS-CoV-2 infection?

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News